Sufficient levels of CLSP activity can suppress all types of neurotoxicity linked to AD in both in vitro and in vivo conditions, even in the presence of overwhelming neurotoxic insults (14, 18–20). The gene discussed is CALML5; the disease is Alzheimer disease.